Stroke & Neurorehabilitation

Overview

A cerebrovascular accident (CVA), commonly known as a stroke, occurs when blood flow to a part of the brain is interrupted or reduced, preventing brain tissue from receiving oxygen and nutrients. Within minutes, brain cells begin to die. Neurorehabilitation is a specialized, multidisciplinary intervention designed to restore function, promote neuroplasticity, and maximize independence following neurological injury. Together, acute stroke management and structured neurorehabilitation form the cornerstone of modern stroke care, significantly reducing mortality and improving long-term functional outcomes.

Pathophysiology

The core pathophysiological event in stroke is ischemia or hemorrhage within the cerebrovascular system, triggering a cascading series of cellular and molecular events known as the ischemic cascade. Key mechanisms include:

• Excitotoxicity: Glutamate overrelease activates NMDA and AMPA receptors, causing excessive calcium influx into neurons.
• Oxidative Stress: Reactive oxygen species (ROS) damage lipids, proteins, and DNA.
• Inflammation: Microglial activation and cytokine release (IL-1β, TNF-α) amplify tissue injury.
• Apoptosis & Necrosis: Delayed cell death pathways contribute to penumbral tissue loss over hours to days.

The ischemic penumbra—tissue surrounding the irreversibly damaged core—remains metabolically compromised but structurally intact. Salvaging this region through timely reperfusion and neuroprotective strategies is the primary goal of acute intervention.

Classification & Risk Factors

Strokes are broadly classified into two categories:

1. Ischemic Stroke (~87%): Caused by thrombotic or embolic occlusion of cerebral arteries. Subtypes include large-artery atherosclerosis, cardioembolism, small-vessel lacunar disease, and other determined/undetermined causes (TOAST classification).
2. Hemorrhagic Stroke (~13%): Resulting from intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH), often linked to hypertension, amyloid angiopathy, or vascular malformations.

Major modifiable risk factors include hypertension, atrial fibrillation, diabetes mellitus, hyperlipidemia, smoking, sedentary lifestyle, and obesity. Non-modifiable factors encompass age, genetics, and prior stroke or TIA history.

Acute Management

Time is brain. Acute stroke management follows standardized protocols:

• Rapid Assessment: NIH Stroke Scale (NIHSS), non-contrast CT/CTA to differentiate ischemic vs. hemorrhagic etiology.
• Reperfusion Therapy: Intravenous alteplase or tenecteplase within 3–4.5 hours of symptom onset. Mechanical thrombectomy for large vessel occlusion up to 24 hours in selected patients (per DAWN/DEFUSE-3 criteria).
• Secondary Prevention: Antiplatelets (aspirin/clopidogrel), anticoagulants (for AFib), statins, blood pressure control, and lifestyle modification.

Transition to rehabilitation typically begins within 24–72 hours post-stroke, once medical stability is achieved.

Principles of Neurorehabilitation

Modern neurorehabilitation is guided by neuroplasticity—the brain's ability to reorganize synaptic connections in response to experience. Core principles include:

• Early Mobilization: Initiated safely within 24–48 hours to prevent complications (DVT, pneumonia, contractures).
• Task-Specific Training: Repetitive, goal-oriented practice of functional movements drives cortical reorganization.
• Intensity & Dosage: High-repetition, high-intensity protocols yield superior outcomes compared to low-dose therapy.
• Constraint-Induced & Bimanual Training: Forcing use of the affected limb or coordinating both hands enhances motor recovery.
• Compensatory Strategies: Teaching alternative movement patterns or assistive device use when full recovery is unlikely.

"Neurorehabilitation is not passive recovery; it is active neural remodeling guided by targeted sensory-motor experience." — Aevum Neurology Consensus, 2024

Therapeutic Modalities

Multidisciplinary teams coordinate interventions across domains:

• Physical Therapy (PT): Gait training, balance, strength, spasticity management, and endurance conditioning.
• Occupational Therapy (OT): Upper extremity function, activities of daily living (ADLs), cognitive-perceptual rehabilitation, and home modifications.
• Speech-Language Pathology (SLP): Aphasia therapy, dysphagia management, cognitive-communication training, and augmentative communication.
• Neuropsychology: Assessment and intervention for depression, executive dysfunction, attention deficits, and emotional lability.
• Pharmacological Adjuncts: Serotonergic agents, amantadine, and tDCS-titrated protocols to enhance plasticity (off-label/research contexts).

Technology & Innovation

Digital and assistive technologies are transforming neurorehabilitation:

• Robotic Exoskeletons: Provide high-repetition, precise joint movements for gait and upper-limb training (e.g., Lokomat, Armeo).
• Voice & Motion Control Interfaces: Enable affected individuals to interact with therapy software despite limited mobility.
• Brain-Computer Interfaces (BCI): Translate motor intention into assistive device control or neurofeedback stimulation, facilitating cortical reactivation.
• Pharmacological & Wearable Sensors: Track adherence, quantify movement quality, and enable remote monitoring.

Prognosis & Outcomes

Recovery follows a non-linear trajectory. The greatest functional gains typically occur within the first 3–6 months, but plasticity-supported improvement can continue for years. Prognostic factors include:

• Severity of initial deficit (NIHSS, mRS at discharge)
• Age, comorbidities, and premorbid function
• Early rehabilitation intensity and adherence
• Psychosocial support and environmental accessibility

Approximately 10–15% of survivors achieve full functional independence, 65–75% require moderate assistance, and 10–15% experience severe disability. Community reintegration, caregiver education, and secondary stroke prevention remain critical to long-term success.